Cargando…

Lower serum FT3 within the reference range is associated with mortality for older adults over 80 years of age with sarcopenia

OBJECTIVE: Thyroid hormones stimulate myogenesis and muscle contraction and regulate skeletal muscle cell metabolism. However, the association between thyroid hormone levels and mortality in sarcopenic older adults remains elusive. The aim of this study was to investigate the relationship between th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Li, Tu, You-Yi, Zhao, Zhe, Jin, Jun, Tao, Jun, Zhang, Xiao-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900526/
https://www.ncbi.nlm.nih.gov/pubmed/36747122
http://dx.doi.org/10.1186/s12877-023-03783-8
_version_ 1784882865831411712
author Zhang, Li
Tu, You-Yi
Zhao, Zhe
Jin, Jun
Tao, Jun
Zhang, Xiao-Yan
author_facet Zhang, Li
Tu, You-Yi
Zhao, Zhe
Jin, Jun
Tao, Jun
Zhang, Xiao-Yan
author_sort Zhang, Li
collection PubMed
description OBJECTIVE: Thyroid hormones stimulate myogenesis and muscle contraction and regulate skeletal muscle cell metabolism. However, the association between thyroid hormone levels and mortality in sarcopenic older adults remains elusive. The aim of this study was to investigate the relationship between thyroid hormones and all-cause mortality in people over 80 years of age with sarcopenia. METHODS: This study was performed on 264 sarcopenic patients aged 80 years and older. Serum levels of thyroid hormone, including free triiodothyronine (FT3), free thyroxine (FT4), and thyroid stimulating hormone (TSH) were tested to evaluate thyroid status. Sarcopenia was defined using the criteria of the European Working Group on Sarcopenia in Older People. Mortality data were available for up to 38 months of follow-up. The correlation between FT3 and calf circumference (CC) or handgrip strength (HGS) was determined by Pearson correlation analysis. Kaplan-Meier analysis was used to compare the differences between FT3 tertile groups. Cox regression was used to analyze the mortality risk ratio of patients with different FT3 tertiles. RESULTS: During the follow-up period, 88 older adults died. Non-Survivors had lower serum FT3 levels (3.7 ± 0.5 vs. 3.9 ± 0.7, P = 0.001) than the Survivor. Serum FT3 was positively associated with CC and HGS (r = 0.29, P < 0.001, r = 0.21, P = 0.002, respectively). The Kaplan-Meier curve analysis demonstrated a difference in mortality among the FT3 tertile groups (log-rank test, χ(2) = 11.83, P = 0.003). The high FT3 group had lower mortality compared with the low FT3 group (the adjusted HRs were 0.63 (95%CI: 0.41–0.96 P = 0.031). CONCLUSION: Lower FT3 within the reference range is associated with higher mortality in adults over 80 years with sarcopenia and euthyroid. Routine assessment of FT3 may be an easy way to identify high-risk older adults with sarcopenia. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-023-03783-8.
format Online
Article
Text
id pubmed-9900526
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99005262023-02-06 Lower serum FT3 within the reference range is associated with mortality for older adults over 80 years of age with sarcopenia Zhang, Li Tu, You-Yi Zhao, Zhe Jin, Jun Tao, Jun Zhang, Xiao-Yan BMC Geriatr Research OBJECTIVE: Thyroid hormones stimulate myogenesis and muscle contraction and regulate skeletal muscle cell metabolism. However, the association between thyroid hormone levels and mortality in sarcopenic older adults remains elusive. The aim of this study was to investigate the relationship between thyroid hormones and all-cause mortality in people over 80 years of age with sarcopenia. METHODS: This study was performed on 264 sarcopenic patients aged 80 years and older. Serum levels of thyroid hormone, including free triiodothyronine (FT3), free thyroxine (FT4), and thyroid stimulating hormone (TSH) were tested to evaluate thyroid status. Sarcopenia was defined using the criteria of the European Working Group on Sarcopenia in Older People. Mortality data were available for up to 38 months of follow-up. The correlation between FT3 and calf circumference (CC) or handgrip strength (HGS) was determined by Pearson correlation analysis. Kaplan-Meier analysis was used to compare the differences between FT3 tertile groups. Cox regression was used to analyze the mortality risk ratio of patients with different FT3 tertiles. RESULTS: During the follow-up period, 88 older adults died. Non-Survivors had lower serum FT3 levels (3.7 ± 0.5 vs. 3.9 ± 0.7, P = 0.001) than the Survivor. Serum FT3 was positively associated with CC and HGS (r = 0.29, P < 0.001, r = 0.21, P = 0.002, respectively). The Kaplan-Meier curve analysis demonstrated a difference in mortality among the FT3 tertile groups (log-rank test, χ(2) = 11.83, P = 0.003). The high FT3 group had lower mortality compared with the low FT3 group (the adjusted HRs were 0.63 (95%CI: 0.41–0.96 P = 0.031). CONCLUSION: Lower FT3 within the reference range is associated with higher mortality in adults over 80 years with sarcopenia and euthyroid. Routine assessment of FT3 may be an easy way to identify high-risk older adults with sarcopenia. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-023-03783-8. BioMed Central 2023-02-06 /pmc/articles/PMC9900526/ /pubmed/36747122 http://dx.doi.org/10.1186/s12877-023-03783-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhang, Li
Tu, You-Yi
Zhao, Zhe
Jin, Jun
Tao, Jun
Zhang, Xiao-Yan
Lower serum FT3 within the reference range is associated with mortality for older adults over 80 years of age with sarcopenia
title Lower serum FT3 within the reference range is associated with mortality for older adults over 80 years of age with sarcopenia
title_full Lower serum FT3 within the reference range is associated with mortality for older adults over 80 years of age with sarcopenia
title_fullStr Lower serum FT3 within the reference range is associated with mortality for older adults over 80 years of age with sarcopenia
title_full_unstemmed Lower serum FT3 within the reference range is associated with mortality for older adults over 80 years of age with sarcopenia
title_short Lower serum FT3 within the reference range is associated with mortality for older adults over 80 years of age with sarcopenia
title_sort lower serum ft3 within the reference range is associated with mortality for older adults over 80 years of age with sarcopenia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900526/
https://www.ncbi.nlm.nih.gov/pubmed/36747122
http://dx.doi.org/10.1186/s12877-023-03783-8
work_keys_str_mv AT zhangli lowerserumft3withinthereferencerangeisassociatedwithmortalityforolderadultsover80yearsofagewithsarcopenia
AT tuyouyi lowerserumft3withinthereferencerangeisassociatedwithmortalityforolderadultsover80yearsofagewithsarcopenia
AT zhaozhe lowerserumft3withinthereferencerangeisassociatedwithmortalityforolderadultsover80yearsofagewithsarcopenia
AT jinjun lowerserumft3withinthereferencerangeisassociatedwithmortalityforolderadultsover80yearsofagewithsarcopenia
AT taojun lowerserumft3withinthereferencerangeisassociatedwithmortalityforolderadultsover80yearsofagewithsarcopenia
AT zhangxiaoyan lowerserumft3withinthereferencerangeisassociatedwithmortalityforolderadultsover80yearsofagewithsarcopenia